Literature DB >> 19680627

Association of inflammation with worsening HOMA-insulin resistance.

K Park1, M Steffes, D-H Lee, J H Himes, D R Jacobs.   

Abstract

AIMS/HYPOTHESIS: We examined the cross-sectional and longitudinal relationships between C-reactive protein (CRP), a marker of low-grade inflammation, and insulin resistance and whether the association was independent of obesity and oxidative stress.
METHODS: CRP and insulin resistance (homeostasis model assessment of insulin resistance [HOMA-IR]) data were obtained in a population-based, prospective observational study, Coronary Artery Risk Development in Young Adults (CARDIA), during 1992-2006.
RESULTS: CRP showed a significant positive association with insulin resistance, both cross-sectionally and longitudinally (5 year follow-up). The estimated increment in HOMA-IR was 0.34 log(e)(pmol/l x [mmol/l]/156.25) (p value for trend <0.0001) in the highest vs lowest CRP quartiles in cross-sectional analysis, whereas the corresponding estimate was 0.12 (p trend <0.0001) in the highest vs lowest CRP quartiles longitudinally over 5 years. The gradient of HOMA-IR across CRP was attenuated but remained statistically significant after controlling for body fat measurements (0.06 in the highest vs lowest CRP in both cross-sectional [p value for trend = 0.001] and longitudinal analyses [p value for trend = 0.01]), and was little changed by further adjustment for oxidative stress markers (F(2)-isoprostanes and oxidised LDL). There were consistent increments in the levels of HOMA-IR with increasing concentrations of CRP over time. In contrast, higher HOMA-IR did not predict future increases in CRP. Findings were similar using fibrinogen as the predictor variable. CONCLUSIONS/
INTERPRETATION: Although a substantial portion of this association was explained by obesity, CRP was independently related to concurrent and future insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19680627      PMCID: PMC5643149          DOI: 10.1007/s00125-009-1486-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  16 in total

1.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  C-reactive protein is independently associated with glucose but not with insulin resistance in healthy men.

Authors:  Anne G Niehoff; Timon W van Haeften; N Charlotte Onland-Moret; Clara C Elbers; Cisca Wijmenga; Yvonne T van der Schouw
Journal:  Diabetes Care       Date:  2007-03-19       Impact factor: 19.112

3.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

Authors:  J S Yudkin; C D Stehouwer; J J Emeis; S W Coppack
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-04       Impact factor: 8.311

4.  Association between C-reactive protein and insulin resistance in a Japanese population: the Minoh Study.

Authors:  Noriyuki Nakanishi; Tsunehito Shiraishi; Mariko Wada
Journal:  Intern Med       Date:  2005-06       Impact factor: 1.271

5.  Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome.

Authors:  A-C Santos; C Lopes; J T Guimarães; H Barros
Journal:  Int J Obes (Lond)       Date:  2005-12       Impact factor: 5.095

6.  Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years.

Authors:  J V Durnin; J Womersley
Journal:  Br J Nutr       Date:  1974-07       Impact factor: 3.718

7.  Genetically elevated C-reactive protein and ischemic vascular disease.

Authors:  Jeppe Zacho; Anne Tybjaerg-Hansen; Jan Skov Jensen; Peer Grande; Henrik Sillesen; Børge G Nordestgaard
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

8.  Plasma fibrinogen and lung function: the CARDIA Study.

Authors:  Bharat Thyagarajan; David R Jacobs; George G Apostol; Lewis J Smith; Cora E Lewis; O Dale Williams
Journal:  Int J Epidemiol       Date:  2006-03-22       Impact factor: 7.196

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

10.  The expression of TNF alpha by human muscle. Relationship to insulin resistance.

Authors:  M Saghizadeh; J M Ong; W T Garvey; R R Henry; P A Kern
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

View more
  24 in total

1.  Race- and sex-specific associations of parental education with insulin resistance in middle-aged participants: the CARDIA study.

Authors:  Teresa Tamayo; David R Jacobs; Klaus Strassburger; Guido Giani; Teresa E Seeman; Karen Matthews; Jeffrey M Roseman; Wolfgang Rathmann
Journal:  Eur J Epidemiol       Date:  2012-05-08       Impact factor: 8.082

2.  Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4/F4 study.

Authors:  Birgit Klüppelholz; Barbara Thorand; Wolfgang Koenig; Tonia de Las Heras Gala; Christa Meisinger; Cornelia Huth; Guido Giani; Paul W Franks; Michael Roden; Wolfgang Rathmann; Annette Peters; Christian Herder
Journal:  Diabetologia       Date:  2015-07-09       Impact factor: 10.122

3.  Markers of oxidative damage are not elevated in otherwise healthy individuals with the metabolic syndrome.

Authors:  Raymond C-S Seet; Chung-Yung J Lee; Erle C H Lim; Amy M L Quek; Shan-Hong Huang; Chin-Meng Khoo; Barry Halliwell
Journal:  Diabetes Care       Date:  2010-02-25       Impact factor: 19.112

4.  The subgingival microbiome, systemic inflammation and insulin resistance: The Oral Infections, Glucose Intolerance and Insulin Resistance Study.

Authors:  Ryan T Demmer; Alexander Breskin; Michael Rosenbaum; Aleksandra Zuk; Charles LeDuc; Rudolph Leibel; Bruce Paster; Moïse Desvarieux; David R Jacobs; Panos N Papapanou
Journal:  J Clin Periodontol       Date:  2017-01-27       Impact factor: 8.728

5.  Elevated insulin resistance in patients with recurrent aphthous stomatitis.

Authors:  Z Takci; A S Karadag; D T Ertugrul; S G Bilgili
Journal:  Clin Oral Investig       Date:  2014-10-28       Impact factor: 3.573

6.  Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy.

Authors:  M Guzmán-Fulgencio; J Berenguer; M García-Álvarez; D Micheloud; J C López; J Cosín; I Fernández de Castro; P Catalán; P Miralles; S Resino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-03-26       Impact factor: 3.267

7.  Sex differences in urinary biomarkers of vascular and endothelial function in HIV-infected persons receiving antiretroviral therapy.

Authors:  Michael S Boger; Aihua Bian; Ayumi Shintani; Ginger L Milne; Jason D Morrow; Husamettin Erdem; Valerie Mitchell; David W Haas; Todd Hulgan
Journal:  Antivir Ther       Date:  2011-12-14

8.  Sex differences in the association between depression, anxiety, and type 2 diabetes mellitus.

Authors:  Ryan T Demmer; Sara Gelb; Shakira F Suglia; Katherine M Keyes; Allison E Aiello; Paolo C Colombo; Sandro Galea; Monica Uddin; Karestan C Koenen; Laura D Kubzansky
Journal:  Psychosom Med       Date:  2015-05       Impact factor: 4.312

9.  Circulating levels of inflammatory markers in intrauterine growth restriction.

Authors:  Theodora Boutsikou; George Mastorakos; Marialena Kyriakakou; Alexandra Margeli; Demetrios Hassiakos; Ioannis Papassotiriou; Christina Kanaka-Gantenbein; Ariadne Malamitsi-Puchner
Journal:  Mediators Inflamm       Date:  2010-06-03       Impact factor: 4.711

10.  Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort.

Authors:  Pia Deichgræber; Daniel R Witte; Holger J Møller; Mette V Skriver; Bjørn Richelsen; Marit E Jørgensen; Nanna B Johansen; Annelli Sandbæk
Journal:  Diabetologia       Date:  2016-08-19       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.